2024 / 06

Next Paper
DOI: 10.24075/brsmu.2024.065
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Impact of tumor on the cell cycle and differentiation of hematopoietic stem cells

Aktanova AA1,2, Bykova MV1, Skachkov IP1,2, Denisova VV3, Pashkina EA1,2
About authors

1 Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russia

2 Novosibirsk State Medical University, Novosibirsk, Russia

3 Immunopathology Clinic, Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russia

Correspondence should be addressed: Alina A. Aktanova
Yadrintsevskaya, 14, Novosibirsk, 630099, Russia; ur.liam@la_avonatka

About paper

Funding: the study was supported by the Russian Science Foundation, project No. 23–25-10099.

Author contribution: Aktanova AA — study design, experimental procedure, data analysis and interpretation, manuscript writing and editing; Bykova MV — literature review, data interpretation, manuscript editing; Skachkov IP — sample preparation, handling illustrations; Denisova VV — providing the biomaterials for the study, advising; Pashkina EA — planning, developing and editing the study design, data analysis, manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Research Institute of Fundamental and Clinical Immunology (protocol No. 145 dated 19 April 2024). All the conditionally healthy donors submitted the informed consent to participation in the study.

Received: 2024-12-02 Accepted: 2024-12-16 Published online: 2024-12-27
|
  1. Treichel S, Filippi M-D. Linking cell cycle to hematopoietic stem cell fate decisions. Front Cell Dev Biol. 2020; 11:1231735. DOI: 10.3389/fcell.2023.1231735.
  2. Szade K, Gulati GS, Chan CKF, Kao KS, Miyanishi M, Marjon KD, et al. Where Hematopoietic Stem Cells Live: The Bone Marrow Niche. Antioxid Redox Signal. 2018; 10; 29 (2): 191–204. DOI: 10.1089/ars.2017.7419.
  3. Baldridge MT, King KY, Goodell M.A. Inflammatory signals regulate hematopoietic stem cells. Trends in Immunology. 2011; 32 (2), 57–65. DOI: 10.1016/j.it.2010.12.003.
  4. Chavez JSPU, Loeffler D, Higa KC, Hernandez G, Mills TS. PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress. Exp Med. 2011; 218 (6), e20201169. DOI: 10.1084/jem.20201169.
  5. Pietras EM, Warr MR, Passegué E. Cell cycle regulation in hematopoietic stem cells. Cell Biol. 2011; 195 (5): 709–20. DOI: 10.1083/jcb.201102131.
  6. Grinenko T, Eugster A, Thielecke L, et al. Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice. Nat Commun. 2018; 9, 1898. DOI: 10.1038/s41467-018-04188-7.
  7. Han W, Yu Y, Liu XY. Local signals in stem cell-based bone marrow regeneration. Cell Res. 2006; 16: 189–95. DOI: 10.1038/sj.cr.7310026.
  8. Lu IN, Dobersalske C, Rauschenbach L, et al. Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression. Nat Commun. 2021; 12, 3895. DOI: 10.1038/s41467-021-23995-z.
  9. Hassan G, Seno M. Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments. Cells. 2020; 9 (5): 1293. DOI: 10.3390/cells9051293.
  10. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ. Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007; 82 (6): 463–72. DOI: 10.1002/ajh.20707.
  11. Katayama Y, Yano T, Bessho A, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant. 1997; 19: 283–7. DOI: 10.1038/sj.bmt.1700644.
  12. Bejarano L, Jordāo MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discovery. 2021; 4 (11): 933– 59. DOI: 10.1158/2159-8290.CD-20-1808.
  13. Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Research. 2019; 18 (79): 4557–67. DOI: 10.1158/0008-5472.CAN-18-3962.
  14. Najafi M, Goradel NH, Farhood B, et al. Tumor microenvironment: Interactions and therapy. Journal of Cellular Physiology. 2019; 5 (234): 5700–21. DOI: 10.1002/jcp.27425.
  15. Edel MJ, Menchon C, Vaquero JM, et al. A protocol to assess cell cycle and apoptosis in human and mouse pluripotent cells. Cell Commun Signal. 2011; 9 (8): DOI: 10.1186/1478-811X-9-8.
  16. Magidey-Klein K, Kveler K, Cooper TJ, Normand R, Zhang T, Timaner M, Raviv Z, et al. Tumor-educated uncommitted hematopoietic stem cells promote a metastatic switch BioRxiv. 2020; DOI: https://doi.org/10.1101/2020.08.25.266189.
  17. Wang X, Li Y. The disruption of hematopoiesis in tumor progression. Blood Sci. 2019; 1 (1): 88–91. DOI: 10.1097/BS9.0000000000000001.
  18. Lu IN, Dobersalske C, Rauschenbach L, et al. Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression. Nat Commun. 2021; 12, 3895. DOI: 10.1038/s41467-021-23995-z.